BPG is committed to discovery and dissemination of knowledge
Featured Articles
3/15/2019 7:25:40 AM | Browse: 849 | Download: 2049
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 43001
Country South Korea
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Retrospective Cohort Study
Article Title Hepatic resection vs percutaneous radiofrequency ablation of hepatocellular carcinoma abutting right diaphragm
Manuscript Source Invited Manuscript
All Author List Kyoung Doo Song, Hyo Keun Lim, Hyunchul Rhim, Min Woo Lee, Tae Wook Kang, Yong Han Paik, Jong Man Kim and Jae-Won Joh
Funding Agency and Grant Number
Corresponding Author Hyo Keun Lim, MD, PhD, Professor, Department of Radiology and Department of Health Sciences and Technology, Samsung Medical Center, SAIHST, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, South Korea. hyokeun.lim@samsung.com
Key Words Hepatic resection; Radiofrequency ablation; Hepatocellular carcinoma; Diaphragm; Treatment outcome
Core Tip The aim of this study was to compare the long-term therapeutic outcomes of hepatic resection and percutaneous radiofrequency (RF) ablation for hepatocellular carcinomas abutting the diaphragm. The disease-free survival (DFS) rate was 64.1% and 18.3% for the hepatic resection group and the RF ablation group, and overall survival (OS) rate was 88.4% and 68.7% for the hepatic resection group and the RF ablation group at 5 years. The local tumor progression rate was as high as 46.6% for the RF ablation group. Although OS was not significantly different between two groups, DFS was better in the hepatic resection group.
Publish Date 2019-03-15 06:26
Citation Song KD, Lim HK, Rhim H, Lee MW, Kang TW, Paik YH, Kim JM, Joh JW. Hepatic resection vs percutaneous radiofrequency ablation of hepatocellular carcinoma abutting right diaphragm. World Journal of Gastrointestinal Oncology 2019; 11(3): 227-237
URL https://www.wjgnet.com/1948-5204/full/v11/i3/227.htm
DOI https://dx.doi.org/10.4251/wjgo.v11.i3.227
Full Article (PDF) WJGO-11-227.pdf
Full Article (Word) WJGO-11-227.docx